PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
90,891
90,891
78,626
93,468
90,714
Cost of Revenue
56,315
56,315
53,530
58,809
46,554
Gross Profit
34,576
34,576
25,096
34,659
44,160
Operating Expenses
Research Development
59,630
59,630
62,594
65,324
67,617
Selling General and Administrative
75,491
75,491
63,489
59,119
47,787
Total Operating Expenses
135,121
135,121
126,083
124,443
115,404
Operating Income or Loss
-100,545
-100,545
-100,987
-89,784
-71,244
Interest Expense
2,611
2,611
2,423
2,921
3,234
Total Other Income/Expenses Net
19,022
19,022
848
516
103
Income Before Tax
-84,134
-84,134
-102,562
-92,189
-74,375
Income from Continuing Operations
-84,134
-84,134
-102,562
-92,189
-74,375
Net Income
-84,134
-84,134
-102,562
-92,189
-74,375
Net Income available to common shareholders
-84,134
-84,134
-102,562
-92,189
-74,375
Basic EPS
-
-0.55
-0.76
-0.87
-0.83
Diluted EPS
-
-0.55
-0.76
-0.87
-0.83
Basic Average Shares
-
152,527
135,094
105,682
89,148
Diluted Average Shares
-
152,527
135,094
105,682
89,148
EBITDA
-
-71,575
-92,924
-80,826
-67,266